| Objective: To observe Shugan Heweijiangni soup treatment of hepatogastric Yuthermal type reflux esophagitis (Reflux esophagitis), clinical efficacy, and clinical andtheoretical perspectives to explore the Qing in Jiangni Decoction RE mechanism.Method: Choose from March2012to February2013, received treatment in ShandongProvince Hospital stomach illness outpatient meet RE (hepatogastric swelter type)diagnosed60patients with clinically selected patients with RE met the inclusion criteria,60patients were randomly divided into two experimental group (30cases) given orallysoup decoction Shunganheweijiangni the control group (30cases) to give domperidonetablets10mg and omeprazole enteric-coated capsules20mg,8weeks, were observed aftertreatment the clinical efficacy and relapse rateResults:1TCM cure rate+markedly effective in the experimental group was75.76%,the control group was43.22%;2. Gastroscopy cure rate+markedly effective treatment, theexperimental group was86.47%, the control group was62.30%, compared to the twogroups significant difference (P <0.05) or non-significant difference (P <0.01). Treatmentgroup than the control group.Conclusion: Shuganheweijingni Decoction is the clinical treatment of type REhepatogastric swelter valid prescription, which can significantly improve the patient’ssymptoms and signs, and its mechanism may be related to inhibition of gastric acidsecretion, gastric emptying, and other effects related esophageal mucosal repair. |
PDF Full Text Request